Velan Capital Investment Management LP

Overview

• HeadquartersAlpharetta, United States²
• Legal formLimited Partnership²
• Kind of organizationLimited partnership²
• LEI254900O0LNRRSI92C739²
• StatusActive²
• LEI statusIssued and current²
• Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States²
• Registered withDivision of Corporations, Department of State, 7839102²

See how the biggest companies compare on our leaderboards

Corporate structure

Velan Capital Investment Management LP sits at the top of its group. 10 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (8 companies). Each entity in the chart links to its source.

Timeline

1. Feb 6, 2020Founded Velan Capital Investment Management LP is founded²

Filings

22 filings to the SEC since October 2021: 22 other. The latest 20:

1. Aug 28, 2026N-PX EDGAR
2. Aug 14, 202613F-HR EDGAR
3. May 15, 202613F-HR EDGAR
4. Feb 13, 202613F-HR EDGAR
5. Nov 14, 202513F-HR EDGAR
6. Aug 29, 2025N-PX EDGAR
7. Aug 14, 202513F-HR EDGAR
8. May 15, 202513F-HR EDGAR
9. Feb 14, 202513F-HR EDGAR
10. Nov 14, 202413F-HR EDGAR
11. Aug 29, 2024N-PX EDGAR
12. Aug 14, 202413F-HR EDGAR
13. May 14, 202413F-HR EDGAR
14. Feb 14, 202413F-HR EDGAR
15. Nov 13, 202313F-HR EDGAR
16. Aug 11, 202313F-HR EDGAR
17. May 15, 202313F-HR EDGAR
18. Feb 13, 202313F-HR EDGAR
19. Nov 14, 202213F-HR EDGAR
20. Aug 15, 202213F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Velan Capital Investment Management LP has told the SEC it owns more than 5% of 8 companies, latest first (Schedules 13D and 13G).

• Edesa Biotech, Inc.SCHEDULE 13D/A Jan 6, 2023 to Aug 25, 2026³
• Jasper Therapeutics, Inc.SCHEDULE 13G Jan 27, 2023 to Aug 17, 2026⁴
• InspireMD, Inc.SCHEDULE 13G/A Aug 6, 2025 to May 15, 2026⁵
• Proteon TherapeuticsSC 13G Dec 17, 2024⁶
• Outlook Therapeutics, Inc.SC 13G/A Mar 28, 2024 to Nov 7, 2024⁷
• Alimera SciencesSC 13D/A Mar 31, 2023 to Sep 16, 2024⁸
• Praxis Precision Medicines, Inc.SC 13D/A Mar 20, 2023 to Jun 28, 2023⁹
• Radius Health, Inc.SC 13D/A Mar 7, 2022 to Aug 26, 2022¹⁰